Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - CAPITAL EXPENDITURES
Capital Expenditures KPTI - Karyopharm Therapeutics Inc.
-142 K
LAST VALUE
-9.70%
2 YEAR CAGR
7.17%
5 YEAR CAGR
25.87%
10 YEAR CAGR